Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SMALL CELL LUNG CARCINOMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946836
What this trial is testing

Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical Study

Who this might be right for
Resectable Non-small Cell Lung CancerBispecific AntibodyNeoadjuvant Therapy
Shanghai Pulmonary Hospital, Shanghai, China 80
Not applicableUnknownNCT02273271
What this trial is testing

Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo

Who this might be right for
Non-small Cell Lung Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC 31
Large-scale testing (Phase 3)Looking for participantsNCT06765109
What this trial is testing

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Who this might be right for
Non-small Cell Lung CancerAnaplastic Lymphoma Kinase-positive
Nuvalent Inc. 450
Large-scale testing (Phase 3)UnknownNCT06110663
What this trial is testing

HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy

Who this might be right for
Non-Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 314
Testing effectiveness (Phase 2)Study completedNCT04212052
What this trial is testing

Split-course Hypofractionated Radiotherapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 104
Not applicableStudy completedNCT04566432
What this trial is testing

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

Who this might be right for
Lung NeoplasmsLung Cancer, Nonsmall CellAdenocarcinoma of Lung+1 more
Geneplus-Beijing Co. Ltd. 252
Testing effectiveness (Phase 2)Ended earlyNCT04958993
What this trial is testing

A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shandong Cancer Hospital and Institute 7
Testing effectiveness (Phase 2)Looking for participantsNCT06840821
What this trial is testing

Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors

Who this might be right for
Advanced Solid Tumors
Mainline Biosciences (Shanghai) Co., Ltd 156
Testing effectiveness (Phase 2)Study completedNCT00492206
What this trial is testing

Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
University of Pittsburgh 40
Testing effectiveness (Phase 2)Ended earlyNCT00343187
What this trial is testing

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Who this might be right for
RashNon-small-Cell Lung Cancer
Allergan 2
Testing effectiveness (Phase 2)Study completedNCT01294306
What this trial is testing

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

Who this might be right for
Adenosquamous Lung CarcinomaBronchioloalveolar CarcinomaLarge Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Looking for participantsNCT06424067
What this trial is testing

Phase 2 Study of Fingolimod in Lung Cancers

Who this might be right for
Non Small Cell Lung CancerSmall-cell Lung Cancer
Medical University of South Carolina 38
Testing effectiveness (Phase 2)UnknownNCT05754736
What this trial is testing

Clinical Study of Ametinib Combined With Bevacizumab in First-line Treatment of Advanced NSCLC With EGFR-mutations.

Who this might be right for
Non-small Cell Lung Cancer
The Second Affiliated Hospital of Shandong First Medical University 50
Very early researchStudy completedNCT04298606
What this trial is testing

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Who this might be right for
Chronic Obstructive Pulmonary DiseaseLung Non-Small Cell CarcinomaPneumonia+5 more
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT02002052
What this trial is testing

Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial

Who this might be right for
Non-small Cell Lung Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 29
Early research (Phase 1)Study completedNCT00330044
What this trial is testing

Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer

Who this might be right for
Inoperable Non Small Cell Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 18
Testing effectiveness (Phase 2)Ended earlyNCT00503971
What this trial is testing

Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.

Who this might be right for
Non-small Cell Lung Cancer
Spanish Lung Cancer Group 33
Not applicableStudy completedNCT04654234
What this trial is testing

Total-body PET/CT Imaging Using the uEXPLORER in Non-small Cell Lung Cancer Patients Treated by Induction Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 15
Testing effectiveness (Phase 2)Looking for participantsNCT05940532
What this trial is testing

A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hunan Cancer Hospital 41
Early research (Phase 1)Study completedNCT00575393
What this trial is testing

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Mayo Clinic 17
Next Page